Adam Finn | |
---|---|
Nationality | British |
Education | University of Oxford University of Cambridge University of London [1] |
Medical career | |
Profession | Paediatrician |
Field |
|
Institutions | University of Bristol |
Adam Hugh Roderick Finn is professor of paediatrics at the University of Bristol and head of the Bristol Children's Vaccine Centre. He has been chairman of the World Health Organization (WHO) European Technical Advisory Group of Experts (ETAGE) on Immunization since 2011 [2] and is an ex-officio member of the WHO Strategic Advisory Group of Experts.
He is a member of the British Department of Health Joint Committee on Vaccination and Immunisation (JCVI) and in 2015 was elected president of the European Society for Paediatric Infectious Diseases (ESPID). [3]
Finn was a senior lecturer at the University of Sheffield for 10 years before joining the University of Bristol as professor of paediatrics and head of the Bristol Children's Vaccine Centre. [2]
M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.
The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.
The Oxford Vaccine Group (OVG) is a vaccine research group within the Department of Paediatrics at the University of Oxford. It was founded in 1994 by Professor E. Richard Moxon, was initially based at the John Radcliffe Hospital, and moved in 2003 to its current location in the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) at the Churchill Hospital in Oxford, England. The group, led by Professor Andrew Pollard since 2001, comprises around 75 members across a number of disciplines, including consultants in paediatrics and vaccinology, clinical research fellows, research nurses, statisticians, post-doctoral laboratory scientists, research assistants and DPhil students.
Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. Previously, from October 2017 to March 2019, she was the Deputy Director General of Programmes (DDP) at the World Health Organization.
Jochen H.H. Ehrich is a German pediatric doctor in the fields of nephrology and tropical medicine, professor emeritus and Former Head of the Department of Paediatric Kidney, Liver and Metabolic Diseases at the Children’s Hospital, Hannover Medical School, in Hannover, Germany.
Gagandeep Kang FRS is an Indian microbiologist and virologist who has been leading the work on enteric diseases, diarrheal infections and disease surveillance at the Bill & Melinda Gates Foundation since 2023.
Guan Yi is a Chinese virologist. In 2014, he was ranked as 11th in the world by Thomson Reuters among global researchers in the field of microbiology. He obtained his PhD in microbiology at the University of Hong Kong and is now a professor of microbiology at his alma mater. His research on the viral respiratory disease SARS helped the Chinese government avert the 2004 outbreak of this disease. He is the current director of the State Key Laboratory for Emerging Infectious Diseases University of Hong Kong. In early 2017, Guan warned that the H7N9 influenza virus "poses the greatest threat to humanity than any other in the past 100 years".
Sir Alan Aird Moncrieff, was a British paediatrician and professor emeritus at University of London. He was most notable for developing the first premature-baby unit in 1947. It was Moncrief who recognised and developed the concept of daily parental visits to the ward, which he developed while at Great Ormond Street, well before the need for this became recognised, and with his ward sister, published an article on Hospital Visiting for Children in 1949.
National Immunization Technical Advisory Group (NITAG) is an advisory committee consisting of multidisciplinary groups of experts responsible for providing information to national governments that is used to make evidence-based decisions regarding vaccine and immunization policy. The majority of industrialized and some developing countries have formally established advisory committees to guide immunization policies; other countries are working towards establishment of such committees.
Noni E. MacDonald is a Canadian physician. She is a Professor in the Department of Pediatrics and former Dean of the Faculty of Medicine at Dalhousie University. In 2019, MacDonald was awarded the Order of Nova Scotia and Order of Canada.
Sir Jonathan Stafford Nguyen Van-Tam is a British physician specialising in influenza, including its epidemiology, transmission, vaccinology, antiviral drugs and pandemic preparedness.
Nicola Mary Turner is a New Zealand public health advocate who is a Professor at the University of Auckland and Medical Director of the Immunisation Advisory Centre, an organisation that advises the New Zealand medical profession and the New Zealand Government. She has contributed to advisory committees for the New Zealand Ministry of Health, is a spokesperson for the Child Poverty Action Group and works in general practice. Much of her research and outreach has focused on improving immunisation coverage and closing equity gaps for the national schedule vaccine delivery in New Zealand and she has commented publicly on these issues during COVID-19 in New Zealand.
CoronaVac, also known as the Sinovac COVID-19 vaccine, was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.
Sir Andrew John Pollard is the Ashall Professor of Infection & Immunity at the University of Oxford and a Fellow of St Cross College, Oxford. He is an Honorary Consultant Paediatrician at John Radcliffe Hospital and the Director of the Oxford Vaccine Group. He is the Chief Investigator on the University of Oxford COVID-19 Vaccine trials and has led research on vaccines for many life-threatening infectious diseases including typhoid fever, Neisseria meningitidis, Haemophilus influenzae type b, streptococcus pneumoniae, pertussis, influenza, rabies, and Ebola.
The Strategic Advisory Group of Experts (SAGE) is the principal advisory group to World Health Organization (WHO) for vaccines and immunization. Established in 1999 through the merging of two previous committees, notably the Scientific Advisory Group of Experts and the Global Advisory Group by Director-General of the WHO Gro Harlem Brundtland. It is charged with advising WHO on overall global policies and strategies, ranging from vaccines and biotechnology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but all vaccine-preventable diseases. SAGE provide global recommendations on immunization policy and such recommendations will be further translated by advisory committee at the country level.
Shabir Ahmed Madhi, is a South African physician who is professor of vaccinology and director of the South African Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, and National Research Foundation/Department of Science and Technology Research Chair in Vaccine Preventable Diseases. In January 2021, he was appointed Dean of the Faculty of Health Sciences at the University of the Witwatersrand.
Peter Jüni is a Swiss physician, general internist, and epidemiologist based in England.
Julie Leask, also known as Julie-Anne Leask, is an Australian social scientist and professor in the School of Public Health and Sydney Infectious Diseases Institute at the University of Sydney, Australia. She is a leading researcher on social and behavioural aspects of vaccination and infectious disease prevention. Leask's research focuses on vaccine uptake, communication, strengthening vaccination programs and policy. Her flagship project is Sharing Knowledge About Immunisation (SKAI), a vaccination communication package designed to improve vaccination conversations between parents and health care workers. Additionally, Leask is an advisor to the World Health Organization (WHO) on vaccine acceptance and demand issues and was the chair of the WHO Measuring Behavioural and Social Drivers of Vaccination working group (2018–2022).